20 June 2017 | News
The institute is also organising an exhibition to highlight CDRI's contribution in the drug discovery and development for PM.
The CSIR-Central Drugs Research Institute (CDRI) will brief Prime Minister Narendra Modi about three new drugs being developed by the Institute on his visit to the campus.
Modi is also president of the Council of Scientific and Industrial Research (CSIR) and this will be his first visit to any of its labs in the country. The institute is also organising an exhibition to highlight CDRI's contribution in the drug discovery and development for PM.
The three drugs that will be talked about are an anti-malarial, osteoporosis and a drug to treat a blood clot. Further, the institute recently held an inspection for Good Laboratory Practices (GLP) certification. The GLP certification will give institute's drugs an international acceptance.
Phase 1 clinical trial for multiple doses of the anti-malarial drug has been done. It may prove to be an effective new way to treat malaria. For the osteoporosis drug which has national and international patent, the clinical trial for single dose have been done and it will help in speedy bone recovery.
PM will be visiting the exhibition first and then move to the Molecular Structural Biology Laboratory and the Natural products chemistry laboratory having 85,000 compounds.